AIDS Pandemic Provokes Alarming Reassessments Of Infectious Disease

In 1900, infectious disease was the leading cause of mortality in the United States, accounting for at least 37 percent of deaths. By 1950, this had been mitigated to 6.8 percent and, by 1989, to 2.8 percent, with corresponding improvements in life expectancy. These numbers, of course, must be taken with a grain of salt, given the eventual preemptive role of infection in chronic illness, and many disorders whose infectious etiology is still to be recognized. Further, the relative importance

Written byJoshua Lederberg
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Further, the relative importance of sanitation, health education, and nutrition--in contrast to medical interventions like immunization and antibiotics--has remained in contentious debate. Regardless, this achievement is trumpeted as the conquest of infectious disease--a glorious tribute, indeed, to public health and medical science.

In consequence, health research since 1950 has ever more emphasized chronic constitutional afflictions like cancer, cardiovascular disease, and psychiatric disorders to the relative neglect of infection. Environmental anxieties are focused on radiation and chemical toxins rather than arthropod vectors and airborne contagion.

Our complacency over the triumph of the human over the microbial has been shaken by the global HIV pandemic. In truth, the majority of the world's population has never been relieved of its load of malaria, tuberculosis, diarrheal disease, and a host of parasitoses. It has taken AIDS to provoke a new look at the threats to human health in the U.S. from infections recently thought ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies